| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0032 | 1 |